Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

NCT04886518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Myotonic Dystrophy 1
Excessive Daytime Sleepiness

Interventions

DRUG: Pitolisant Oral Tablet
DRUG: Placebo oral tablet

Sponsor

Harmony Biosciences Management, Inc.